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Crystal structure of a colicin N fragment suggests a model
for toxicity
Ingrid R Vetter†*, Michael W Parker‡*, Alec D Tucker§, Jeremy H Lakey#,
Franc Pattus¶ and Demetrius Tsernoglou¥
Background:  Pore-forming colicins are water-soluble bacteriocins capable of
binding to and translocating through the Escherichia coli cell envelope. They
then undergo a transition to a transmembrane ion channel in the cytoplasmic
membrane leading to bacterial death. Colicin N is the smallest pore-forming
colicin known to date (40 kDa instead of the more usual 60 kDa) and the crystal
structure of its membrane receptor, the porin OmpF, is already known.
Structural knowledge of colicin N is therefore important for a molecular
understanding of colicin toxicity and is relevant to toxic mechanisms in general.
Results: The crystal structure of colicin N reveals a novel receptor-binding
domain containing a six-stranded antiparallel β sheet wrapped around the
63 Å long N-terminal α helix of the pore-forming domain. The pore-forming
domain adopts a ten α-helix bundle that has been observed previously in the
pore-forming domains of colicin A, Ia and E1. The translocation domain,
however, does not appear to adopt any regular structure. Models for receptor
binding and translocation through the outer membrane are proposed based
on the structure and biochemical data.
Conclusions: The colicin N–ompF system is now the structurally best-defined
translocation pathway. Knowledge of the colicin N structure, coupled with the
structure of its receptor, OmpF, and previously published biochemical data,
limits the numerous possibilities of translocation and leads to a model in which
the translocation domain inserts itself through the porin pore, the
receptor-binding domain stays outside and the pore-forming domain
translocates along the outer wall of the trimeric porin channel.
Introduction
Colicins are plasmid-encoded bacteriocins, produced by
Escherichia coli, that kill sensitive E. coli strains and related
bacteria (for recent reviews see [1–5]). The cell envelope
of gram negative bacteria, with its two membranes, pre-
sents a serious obstacle for the uptake of macromolecules
of the size of colicins (40–60 kDa). To cross this barrier
and reach their target, colicins must first bind to their
cognate receptor on the cell surface and then translocate
across the outer membrane. The pore-forming colicins (E1,
A, B, N, Ia, Ib, K, 10 and 5) and colicin M, an inhibitor of
murein biosynthesis, insert into the inner membrane,
whereas colicins with nuclease activity (E2–E9 and cloacin
DF13) must enter the cytoplasm. Uptake of colicins
through the outer membrane follows two alternative path-
ways mediated by the Ton or Tol systems. These two
systems are also involved in the transport of bacteriophage
DNA into the cells. The Ton system consists of the pro-
teins TonB, ExbB and ExbD and is also involved in the
energy-dependent uptake of vitamin B12 and iron sidero-
phores [6,7]. The Tol system consists of six proteins:
TolA, TolB, TolQ, TolR, PAL and Orf2 [8,9]. Group B
colicins (B, D, Ia, Ib, M, 5 and 10) are taken up via the Ton
pathway, whereas the translocation of group A colicins (A,
E1–9, K, N and cloacin DF13) involves interaction with
TolA and different combinations of the proteins from the
Tol family [10–12]. Additional proteins are also essential
for the translocation of some colicins: the porin OmpF for
colicins A, K and N; TolC for colicins E1 and 10; and
OmpA for colicin K [13].
Colicins consist of distinctive protein modules, which pre-
sumably originated from the genetic recombination of
DNA fragments that encoded for different specialized func-
tions. The N-terminal domain specifies the translocation
route (Ton or Tol pathways), a central domain specifies the
receptor, and a C-terminal domain carries the killing activ-
ity. Colicins E1 and 10 contain a fourth domain, the TolC
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domain, located between the translocation and the receptor
domains [14]. TonB-dependent colicins contain a homolo-
gous sequence of five amino acids, called the TonB box, in
their N-terminal translocation domain, which is also present
in TonB-dependent receptors [15]. The Tol-dependent col-
icins possess a glycine-rich and proline-rich region in their
N-terminal translocation domains. The existence of a TolA
box has been proposed with the following motif: Asp–Gly–
(Ser,Thr)–Gly–Trp [14]. But mutation of serine in this
motif to phenylalanine in colicin E3 inhibits TolB binding
instead [12] and the motif is present in only one subset of
Tol-dependent colicins. Another TolA box with the motif
Glu–Gly–Gly–Gly–Ser has been proposed for protein III of
phage f1 [16]. There is experimental evidence that the
N-terminal domains of both group A and group B colicins
interact with components of the translocation system on the
inner side of the outer membrane; translocation through the
outer membrane therefore occurs during colicin uptake.
Mutations in the TonB box of colicins B and M impaired
uptake, but this was partially restored by a mutation in
TonB [17]. Expression of the N-terminal domain of either
colicin B or colicin E3 in the periplasm make E. coli strains
tolerant to the corresponding colicins [12].
Pore-forming colicins induce voltage-dependent potass-
ium and phosphate efflux across the plasma membrane of
the target bacterium [18] and form voltage-gated ion chan-
nels in artificial membranes [19–23]. The pore activity is
carried by the C-terminal domain [20,23]. Near the car-
boxyl end of the pore-forming domain is a hydrophobic
segment present in all the pore-forming colicins. The
crystal structure of the pore-forming domain of colicin A,
solved to 2.4 Å resolution, revealed that this hydrophobic
segment forms a buried α-helical hairpin, surrounded by
an outer bundle of eight amphipathic helices [24]. A similar
fold has been identified recently in the crystal structures
of the pore-forming domain of colicin E1 and the full-
length colicin Ia [25,26]. A large amount of data have been
accumulated concerning the mechanism of membrane inser-
tion and pore formation by this domain [1–4,27–31]. A uni-
fying model has been proposed recently that reconciles
various proposals on the orientation of the hairpin with
respect to the membrane [32] and segments of the poly-
peptide chain have been identified that move across the
membrane in response to voltage [33,34].
Much less is known about the mechanism of the colicin
interaction with its receptor and the subsequent transloca-
tion of the toxin. The mechanism appears to follow the
general rule that significant unfolding should occur prior
to, or during, translocation [35]. Engineering disulphide
bridges within the pore-forming domain of colicin A slows
down translocation, but does not abolish it completely
[36]. There is some experimental evidence that the colicin
molecule spans the periplasmic space and contacts both
the inner and outer membranes simultaneously [35]. The
recently solved tripartite structure of colicin Ia at 3.0 Å
resolution [26] is compatible with such organization. The
molecule is 210 Å long with the translocation and pore-
forming domains separated from the receptor-binding
domain by a pair of helices, each 160 Å long.
Colicin N, which belongs to the group A colicins, possesses
similar properties and functions to other pore-forming col-
icins, but has a much shorter polypeptide chain (385 amino
acids) and a single receptor. It thus provides a simpler
model system than other colicins for pursuing structure–
function studies. Here, we present the crystal structure, at
3.1 Å resolution, of a large fragment of colicin N (missing
the first 66 residues) that contains the pore-forming and
the receptor-binding domains. The pore-forming domain
adopts the canonical ten helix bundle seen in other colicins
[24–26], whereas the receptor-binding domain adopts a
novel fold. The crystal structure of the colicin N receptor,
the protein ompF, which is one of the major unspecific
porins from E. coli, has been solved previously at 2.4 Å
resolution [37]. The structures have enabled us to look at
possible interactions between the colicin receptor-binding
domain and its receptor, leading to new insights into the
translocation mechanism of colicins.
Results
The pore-forming domain
The structure of colicin N is shown in Figure 1 and the
corresponding topology diagram is presented in Figure 2.
The pore-forming domain of colicin N consists of a bundle
of ten α helices arranged in three layers forming the so-
called ‘globin-like’ topology [38,39], also found in the pore-
forming apoptosis regulatory protein Bcl-xL [40]. This topol-
ogy is identical to that observed in the pore-forming
domains of other colicins (Figure 2; [24–26]). A character-
istic feature of the pore-forming domains of colicins is
their hydrophobic core consisting of a buried helical hairpin,
formed by α helices 8 and 9, and surrounded by a cluster
of aromatic residues. Although the hairpin is present in all
pore-forming colicins, some colicins exhibit extensive dele-
tions in this region, for example colicins E1 and Ia.
Colicin N has a deletion of one amino acid in helix 8 com-
pared to colicin A (corresponding to Leu165 in the colicin A
pore-forming domain; see Figures 3 and 4). In addition,
there is a proline residue (Pro346) close to the site of dele-
tion (which is an alanine in colicin A). These changes do
not shorten the loop adjacent to this helix, but disturb the
structure of the helix itself. The helix loses one helical
turn compared to colicin A, but the conformation of the
proline residue ensures that the loop between helices 8 and
9 nearly retains the same conformation in both colicins
(Figures 3 and 4; [41]).
A remarkable feature of the hydrophobic core is its poor
packing arrangement highlighted by a tube-like channel
(Figure 5). The channel is created by virtue of the structural
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alterations at the C-terminal end of helix 8 (compared to
colicin A), which is six residues shorter than helix 9. The
channel stretches from one side of the molecule almost
through to the other side where it is met by a large depres-
sion formed by the loop between helices 3 and 4. It runs
through the middle of the hydrophobic hairpin and is filled
by four water molecules. The walls of the channel are
formed mostly by hydrophobic residues with the excep-
tions being the sidechains of amino acids Trp365, Tyr347,
Tyr309, Thr362, Ser305 and Trp270 and the mainchain
carbonyls of Leu342 and Ser343. These residues contribute
to the hydrogen bonding network that stabilizes the water
molecules inside the channel.
The receptor-binding domain
The receptor-binding domain consists of a six-stranded
β sheet wrapped around an α helix, which is an extension
of α-helix 1 from the pore-forming domain (Figure 1). In
total, this helix is 63 Å long. The topology and secondary
structure of the receptor-binding domain of colicin N is
shown in Figure 2. Regions showing increased tempera-
ture factors, besides the N terminus, are located around
residues 140, 150 and 164. These regions correspond to
loop regions connecting β strands. There is no significant
sequence similarity of the receptor-binding domains of
colicin N to the other colicins, although OmpF also serves
as a co-receptor of colicin A [10]. A search for similar
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Figure 1
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Structure
Schematic representation of colicin N. (a) The receptor-binding
domain is coloured red and the pore-forming domain is coloured blue.
The hydrophobic helical hairpin is coloured yellow. The cluster of
positively charged residues in the putative binding cleft is shown in
ball-and-stick representation. (b) A view of the receptor-binding
domain viewed from the top of the molecule as shown in (a). These
figures were generated using MOLSCRIPT [70]. (c) An electrostatic
surface representation of the receptor-binding domain highlighting the
solvent-exposed cleft. Red indicates electronegative potential
(< –10 kT) and blue indicates positive potential (> 10 kT). This figure
was generated using GRASP [71].
Figure 2
A topology diagram of the receptor-binding and pore-forming domains
of colicin N.
94
93
97
101
385
372370
352
331326294
343315209260
271
251216214
240230
170 161
157 148
143 137
131 128
122
111
108
114116
155
149
234 236 275 283 289
287
N
C
1
23
4567
1
2 3 4 6
5
7 8 9 10
α
β
α α α α
β β β
β β
α α α α
Structure
topologies in other proteins was conducted using the
program FSSP [39]. The highest structural similarity was
found with the human class I histo-compatibility antigen
AW 68.1 (HLA), for which the root mean square deviation
(rmsd) of mainchain atoms is 2.9 Å. There is no significant
sequence similarity between colicin N and HLA, however.
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Figure 3
A comparison of colicins N and A.
A stereoview of the α-carbon trace of the
superimposed colicin N (red trace) and
colicin A (yellow trace; [41]). This figure was
produced using MOLSCRIPT [70].
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Figure 4
A stereoview comparison of the hydrophobic
helical hairpin of colicin A (yellow; [41]) and
colicin N (green). For clarity only the α-carbon
backbones of the mainchain are shown and
the oxygen atoms of sidechain residues are
coloured red. This figure was produced using
MOLSCRIPT [70].
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Contrary to the HLA molecule, the β strands of the
colicin N receptor-binding domain resemble one half of a
porin-like β barrel when viewed along the axis of central
α-helix 1 (Figure 1b). The relative arrangement of a
β sheet wrapped around an α helix is also found in the pro-
tease inhibitor cystatin [42], although the topology is dif-
ferent. In cystatin, the α helix is connected to the opposite
end of the β sheet compared to colicin N. There is also
some superficial resemblance between the structures of
colicin N and pilin [43]. Although there is no detectable
sequence similarity between the two, both possess a long
helix with a predominantly β-sheet-containing domain teth-
ered to one end. But the β sheet domains are located at
different ends of the helix, the number of strands differ,
the topology of the sheets is different, and pilin possesses
a disulphide bridge. Intriguingly, however, both proteins
translocate across the outer membrane of gram negative
bacterial cells, although in opposite directions.
The most prominent feature of the receptor-binding
domain is the existence of two large clefts formed by the
twisted β sheet (Figure 1). One cleft is formed by the
β sheet wrapping around the long helix and is located
at the interface between the two secondary structures
(Figure 1b). This cleft is all hydrophobic and is particu-
larly rich in aromatic residues. In the crystal structure, the
cleft is completely filled by the long helix. The other cleft
is formed on the opposite side of the sheet to the first cleft
(Figure 1c). Unlike the first cleft, it is empty and fully
solvent exposed. It contains a number of charged amino
acid sidechains including two clusters of positively charged
sidechains in the upper and lower parts of the cleft as well
as two negatively charged residues in the centre of the
cleft. It is tempting to assume that this cleft might be a
ligand-binding pocket based on its shape and unusual
distribution of charged amino acids. During the structure
determination it was noted that heavy atom reagents were
prone to bind in the cleft.
Contacts between the pore-forming and receptor-binding
domains
Besides the connecting α helix, there are few contacts
between the receptor-binding and pore-forming domains.
There are two potential hydrogen bonding interactions:
the mainchain amide of Lys129 to the mainchain oxygen
of Ile326 and the mainchain oxygen of Ser127 to the
mainchain amide of Gly328. In addition, there are six van
der Waals contacts. Thus, the interaction between the
two domains is weak, probably allowing movements of
the domains relative to each other in solution. Although
the colicin N molecules in the crystal pack as head-to-tail
dimers with the possibility of introducing conformational
constraints on the inter-domain movement, it is not very
likely that the weak interaction between the two domains
is an artifact; because the shapes of the two domains are
so different, a fit yielding a sufficiently large contact
surface is impossible. The long helix connecting the two
domains has one outstanding feature, namely a stretch of
charged amino acids (Arg–Lys–Glu–Glu–Lys–Glu–Lys–
Asn–Glu–Lys–Glu) in the region between the two domains
(Arg184–Glu194). Colicin Ia also possesses a highly charged
stretch of sequence proceeding its pore-forming domain.
The function of this stretch in either colicin remains to
be elucidated.
The translocation domain
The translocation domain, located between residues 17
and 66 [44], has a glycine/proline/serine/asparagine-rich
sequence, which is likely to have poorly defined secondary
structure. The translocation domain is absent in the 3.1 Å
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Figure 5
A stereoview showing the water-filled channel
of colicin N running through the centre of the
molecule. Some sidechains are labeled for
better orientation. The water molecules are
shown as red spheres. One water molecule,
which sits in the funnel-shaped entrance to
the channel, cannot be seen in this view.
Other water molecules are located in the
protein core, but have been omitted in this
figure for clarity. The surface was calculated
using the Connolly algorithm [72].
resolution structure, but the majority of it is present in
the initial crystal form (see the Materials and methods
section), which comprises residues 37–387. This region
includes residues 58–61, which has been shown recently to
be essential for binding to TolA [45]. There is no evidence
of any density for the translocation domain; this is in
complete accord with circular dichroism and fluorescence
results, which demonstrate that this domain does not
adopt any regular secondary structure [45,46].
Discussion
A comparison of colicin pore-forming domains
The structure of the pore-forming domain of colicin N
is very similar to the pore-forming domain of colicin A
(Figure 3; [24]) as expected from the high pairwise sequence
identity (56%) and very similar channel properties [22].
The rmsd between the mainchain atoms of the pore-
forming domains of colicin N and the mainchain atoms of
the two monomers in the asymmetric unit of the colicin A
crystal, denoted ‘A’ and ‘B’ respectively [41], is 1.31 Å
and 1.25 Å (for these superpositions, residues 346–349 of
colicin N and 162–166 of colicin A were omitted because
colicin N has a one residue deletion in this region). The
major differences in the superpositions (< 2 Å) were located
at residues 215, 235 and 255 of colicin N compared to mol-
ecule B of colicin A and, additionally, at residues 285 and
325 compared to molecule A of colicin A. The differences
in all these residues can be attributed to crystal contacts,
although differences in the first three residues might also
reflect genuine differences.
Although the sequence similarities of colicin N to the
pore-forming domains of colicins E1 and Ia are quite low
(26% and 22%, respectively), they nevertheless exhibit
very similar folds [25,26]. As well as the canonical ten
helix bundle, the first helix is found to be extended to
form a bridge to the receptor-binding domain present in
the intact toxin. Other common features include the inter-
nal cavities surrounding the hydrophobic hairpin and
patches of positive charge on the surface of the molecule.
The internal cavities might be a key to structural rearrange-
ments required for membrane insertion, whereas the
patches of positive charge may be used for initial docking
of the toxin molecule onto the membrane [41]. A signifi-
cant difference between colicin N and colicins E1 and Ia
is a shorter hydrophobic helical hairpin in colicins E1 and
Ia. In contrast to colicin N, colicin Ia has three additional
helices from the translocation domain, which are packed
against the ten helices of the pore-forming domain [26].
Because the structures of the pore-forming domains of all
the colicins are very similar, it is highly likely that their
mechanism of membrane insertion and channel forma-
tion are also broadly similar. Detailed proposals for the
mechanisms have been put forward and the interested
reader is directed towards recent papers and reviews on
the subject [1–5,25,32,41].
A comparison of colicin receptor-binding and translocation
domains
The receptor-binding domain of colicin N is a novel struc-
ture, quite unlike that found in the crystal structure of
colicin Ia, which has been published recently [26]. But
although colicin Ia belongs to the group B colicins and
bears no sequence similarity with colicin N outside the
region of the pore-forming domains, there are a number of
interesting similarities in the structure and function of
the two colicins. The receptor for colicin Ia is Cir, an outer
membrane protein that probably adopts a β-barrel topol-
ogy similar to that of OmpF [5]. The TonB translocation
machinery used by colicin Ia is analogous to the TolA
system used by colicin N. Both TonB and TolA are thought
to form extended rods that span the periplasm with an
anchor in the periplasmic membrane. Accessory proteins
(TolQ/TolR and ExbB/ExbD) in each system show signif-
icant sequence similarity [3,8]. The C-terminal domains of
TonB and TolA are thought to provide binding sites for
colicin translocation domains [47].
In colicin Ia, the receptor-binding and pore-forming
domains are separated by a pair of 160 Å long helices.
This compares with the single long 63 Å helix in colicin N.
The receptor-binding domains of the two colicins share a
superficial resemblance in that they both consist of a
curved β sheet wrapped around a central, long α helix,
which extends into the pore-forming domain to form the
first helix of this domain. In the case of colicin Ia, however,
the β sheet is composed of only two strands. Unlike
colicin N, the much larger translocation domain of colicin Ia
partially adopts regular secondary structure: three long
helices. Interestingly, the TonB box is located in an
extended coil of ~70 residues at the N terminus, which is
about the same size as the entire colicin N translocation
domain. Thus, in both colicins the precise region thought
to interact with the translocation machinery adopts no
structure and this flexibility maybe a key part of the
recognition process.
Implications for the interaction of colicin N with OmpF
Colicin N has only one receptor, the matrix porin OmpF.
This is in contrast to colicin A, which requires two differ-
ent receptors, OmpF and BtuB, both located in the outer
cell membrane [48]. Colicin N requires its receptor for full
activity in vivo and the related porins, PhoE and OmpC,
are associated with greatly reduced cellular sensitivities to
colicin N [49,50]. Colicin N can bind to the three porins
with similar affinity in vitro indicating that the complexes
with PhoE and OmpC are poorly competent for transloca-
tion in vivo [51]. The OmpF protein has been closely inves-
tigated for its involvement in the reception and translo-
cation steps of colicin N entry [50,52–54] and its crystal
structure is known at 2.4 Å resolution [37]. Although all
the domains of colicin N are mainly basic, the OmpF extra-
cellular loops are mainly acidic. Several regions of OmpF
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have been identified that are necessary for the receptor-
binding and the translocation steps of colicin N. Point
mutations of Glu284 and Gly285, which are located on the
outer rim of the porin channel, indicate that these residues
are necessary for colicin N binding, but not for transloca-
tion [53]. Another colicin N-resistant point mutant is
Gly119→Asp, which is located in a loop within the porin
pore, suggesting that the binding site is either deep inside
the pore or that the pore represents part of the transloca-
tion pathway [53]. It is clear from looking at the size and
shape of the colicin N molecule that the receptor-binding
domain cannot possibly bind to residue 119. Even if one
postulated conformational changes of OmpF in the region
of residue 119, the domain cannot bind to residue 119 and
residues 284 and 285 simultaneously. The crystal structure
of the OmpF mutant, Gly119→Asp, is known and shows
only minor conformational changes [55]. Indeed, the muta-
tion subdivides the existing pore into two smaller pores,
suggesting that the effect of the mutation is to block the
passage of some part of colicin N.
These results suggest only one model of binding (Figure 6).
In this model the colicin N receptor-binding domain sits
like a plug above the pore of OmpF, with the pore-forming
domain interacting with the outer rim and residues 284 and
285 of OmpF, and the translocation domain reaches down
to, or past, residue 119. The solvent-exposed cleft in the
colicin N receptor-binding domain forms interactions with
the porin and there is a complementary interaction between
the positively charged surface of the colicin and the nega-
tively charged surface provided by the porin loops. There is
experimental evidence that the translocation and the pore-
forming domains contribute significantly to the binding
affinity: the receptor-binding domain (R) of colicin N alone
or attached to the translocation domain (RT) have been
overexpressed, purified and their affinity for OmpF, both in
vivo and in vitro, were compared to the full-length colicin N
and the fragment studied here (RP; [46]). All the two-
domain fragments display a weaker affinity for OmpF than
full-length colicin N, suggesting that molecular recognition
is a property of the receptor domain but affinity is influ-
enced by the entire molecule. This model also predicts
that the OmpF pore would close on colicin N binding,
which agrees with experiments in which the isolated
R domain is found to block OmpF channels (J.H.L. and
F.P., unpublished observations).
The translocation process and channel formation
The Tol machinery is located at adhesion zones between
the two bacterial membranes. TolA is anchored through
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Figure 6
The proposed model for colicin N receptor-binding and translocation.
The trimeric porin, OmpF, is shown in the outer membrane and Tol
proteins are shown projecting into the periplasm from the inner
membrane. For simplicity, the receptor-binding domain of colicin N is
shown as a cusp-shaped object and the pore-forming domain is
indicated by the cylindrical rods that represent the helices of that
domain. The colicin N molecule is shown approaching the target
membrane and binding to OmpF via its receptor-binding domain. The
translocation domain threads through the porin pore to interact with
TolA in the periplasm. The pore-forming domain subsequently
translocates to the inner membrane. The closed form of the colicin N
channel is shown in the last panel. Application of a transnegative
voltage would cause the helices lying on the surface of the membrane
to insert and form the open channel.
a single transmembrane stretch to the cytoplasmic mem-
brane. The C-terminal domain of ~120 residues is pre-
dicted to sit at the end of an enormously long helix
that projects into the periplasm [8]. It is the C-terminal
domain that interacts with the translocation domain of
group A colicins [14,56]. Because the C-terminal domain
of TolA resides in the periplasm, the translocation domain
of colicin N must somehow traverse the outer membrane.
Furthermore, the proximity of the receptor-binding domain
to the TolA binding site, which is located at residues
59–62 [45], also provides a limitation on the distance
between TolA and the receptor-binding domain of < 90 Å.
There appear to be three possible distinct routes. The
first is along the outside of the porin barrel, but this
would require direct interaction with the lipid bilayer,
which is energetically unfeasible. Second, the domain
could slip through the porin pore or between a transient
pore created between the monomers of the porin trimer.
The third possibility requires destablization of the
monomer interfaces, for which there is no experimental
evidence. Indeed, the porin trimer is very stable and can
only be dissociated in SDS at temperatures > 75°C [57].
Because the translocation domain appears to form a highly
flexible coil, it is easy to envisage that the 66 residue
domain could poke through the porin pore so as to make
contact with the C-terminal domain of TolA, which is
located underneath (Figure 6). This is also in agreement
with the model presented above in which the transloca-
tion domain was proposed to interact with the OmpF
pore in the initial receptor-binding step.
The final step of the translocation process would be the
passage of other parts of the toxin across the outer mem-
brane. Proteolysis experiments with colicin A suggest
that the receptor-binding domain remains attached to
OmpF after channel formation in the inner membrane
[35]. Engineering disulphide bonds between helices 1 and
2 and between helices 3 and 10 of the pore-forming
domain of colicin A blocked the in vivo activity of the
toxin without affecting pore formation in artificial mem-
branes. These covalent linkages and others in the pore-
forming domain (between helices 2 and 10 and between
helices 3 and 9) did not stop the translocation process
across the outer membrane. These observations lead to
the suggestion that helices 1–3 must span the periplasm
of E. coli when the pore-forming domain is inserted into
the inner membrane [58]. There is presently no evidence
as to whether colicin N also spans both membranes and
the only proteolysis studies on colicin N to date lend no
support to the suggestion [54]. If colicin N did span the
membrane, helix 1 is probably not long enough to span
the entire periplasmic space in order to allow insertion of
the pore-forming domain of colicin N whilst part of the
molecule is still bound to OmpF. It has been shown,
however, that helices 4–10 are sufficient for channel for-
mation [59]. We suggest, by analogy to colicin A, that
helices 1–3 could form a single helix long enough for the
toxin to insert in the cytoplasmic membrane and the
receptor-binding domain can, if required, remain bound
to the outside of the cell. (Because TolA is located at
adhesion zones, it is likely that colicin N translocates at
these sites. Thus, the required separation between the
receptor-binding and pore-forming domains could be less
for colicin N than for other colicins, which translocate at
different sites.) The N-terminal half of helix 1 is suffi-
ciently long to span a membrane and it is amphiphilic so
the hydrophobic face could conceivably interact with the
hydrophobic core of the outer membrane. These struc-
tural rearrangements are supported by calorimetry exper-
iments, which reveal thermodynamics consistent with large
structural changes occurring to colicin N on binding to
OmpF [51] even though the receptor-binding and pore-
forming domains are very stable [46]. The model is also
reminiscent of the model for colicin Ia, which is also pos-
tulated to span the periplasmic space by virtue of the
unusually long helices that bridge the receptor-binding
and pore-forming domains in that molecule [26].
The mechanism by which the pore-forming domain tra-
verses the outer membrane is puzzling. It doesn’t seem
likely that it can pass through the porin pore. First, the
pore would be plugged by the translocation and receptor-
binding domains. Second, to fit through the pore, the
toxin would require complete unfolding. Although the
porin pore is sufficiently wide to allow the passage of the
unstructured translocation domain, it is not wide enough
to allow the passage of fully folded receptor-binding or
pore-forming domains. There is no obvious source to
promote complete unfolding of these domains and previ-
ous studies have shown that both receptor-binding and
pore-forming domains are very stable towards denaturants
[46]. Furthermore, colicin A mutants in which disulphide
bonds have been engineered between various helices of
the pore-forming domain can still be translocated through
the outer membrane [36,58]. There are two alternative
possibilities: transient destabilization of the porin trimer to
create a pore large enough for the pore-forming domain to
slip through; or translocation across the outer surface of
the trimer. The energy costs required for either pathway
could be provided by the toxin binding to the receptor and
the translocation domain ‘switching’ on the translocation
machinery upon binding to TolA. Hybrids of OmpF, and
the related porin OmpC, which bind colicin N but are not
active in colicin N uptake, have been used to map the region
of OmpF required for translocation [52]. The region was
localised on the surface of the porin trimer directly below
the loop containing residues 284 and 285, which have been
implicated in binding (see above), and largely separated
from the pore lumen by an internal long loop (loop L3).
These data support passage across the outer surface of the
trimer. Presumably, the Tol translocation machinery medi-
ates this passage across the outer membrane.
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If, as proposed for colicin A, the receptor-binding domain
remains bound to OmpF, we have suggested a model that
allows the translocation and the pore-forming domains to
translocate to the periplasmic space. It explains the obser-
vation that on initial binding to the receptor, the transloca-
tion domain of colicin N is prone to proteolysis although it
is resistant to proteolysis upon translocation [54]. On
initial binding, the translocation domain would be accessi-
ble to proteases, whereas upon translocation it would have
passed across the membrane. Our current model for colicin
toxicity is summarized in Figure 6.
Biological implications
Colicins are a distinctive class of antibiotics produced by
various strains of Escherichia coli. When induced through
the SOS system, they are secreted into the extracellular
medium with the aid of a lysis protein. Following secre-
tion, the toxin molecules bind to metabolite receptors on
the outer membrane of sensitive cells, thereby par-
asitizing these bacterial transport systems and using
them as entry ports. The translocation across the peri-
plasm is aided by some of the target cell’s transport
machinery. Subsequent killing of the bacterial cell is
achieved by a variety of means, including DNase activ-
ity, RNase activity or pore formation. Pore-forming col-
icins have proved to be powerful model systems for
investigating the mechanisms of protein translocation,
channel formation and function.
Colicin N is the shortest of the known colicins, but still
retains all the functionalities of its relations. Because of
its relative simplicity, it is an ideal system for studying
colicin translocation mechanisms. In addition, the entry
route into the target cell used by colicin N is the same as
that used by filamentous bacteriophages and hence work
on colicin N is also likely to shed light on phage infection.
We have solved the crystal structure of a large fragment
of colicin N which includes the receptor-binding and
pore-forming domains. The pore-forming domain adopts
the canonical globin-like fold of other colicin pore-
forming domains, whereas the receptor-binding domain
adopts a novel fold. Based on the structure and the previ-
ously determined crystal structure of its receptor, OmpF,
it has been possible to produce a plausible model of how
colicin N traverses two membranes to form a voltage-
gated ion channel.
Materials and methods
Protein purification and crystallization
Purification of colicin N was carried out as previously described [60].
Initial crystals were obtained from full-length colicin N. These crystals
were grown by the hanging drop method at room temperature using
reservoir conditions of 50 mM phosphate pH 7.0, 40% (w/v) ammonium
sulphate and 0–5% PEG 6000. These crystals only diffracted to just
beyond 6 Å resolution, however. These crystals took several months to
appear and analysis of the crystals showed that a proteolytic cleavage
had occurred after residue 36. Attempts were then made to crystallize a
proteolytic fragment of the toxin. The production and characterization of
its chymotryptic fragment have been described elsewhere [44]. Crystals
of the chymotryptic fragment of colicin N were grown by the hanging
drop method at room temperature. The protein concentration was
10 mg/ml and the reservoir solution consisted of 50 mM phosphate
buffer (pH 5.6–7.0) and 60% (w/v) saturated ammonium sulphate. Small
crystals appeared after 1–2 days and grew to their full size of up to
0.6 mm × 0.6 mm × 0.6 mm in 1–2 weeks.
Data collection and processing
The full-length colicin N-derived crystals belong to the space group
P4132. A low-resolution data set was collected to 6 Å resolution
(Rsym = 8.9% and 97% complete). The crystals obtained from the chy-
motryptic fragment belong to the cubic spacegroup I4132 with unit cell
parameters of a = b = c = 187.3 Å and with one molecule per asym-
metric unit. The best native data set (to 3.1 Å resolution) was collected
on the X-31 beamline at the Deutsche Elektronen Synchrotron (DESY)
at the European Molecular Biology Laboratory Outstation, Hamburg,
Germany. The wavelength was set to 1.009 Å and data were collected
using a Hendrix-Lentfer imaging plate scanner. Processing was per-
formed using the CCP4 program suite [61] and the data statistics
are presented in Table 1. Diffraction data for the heavy-atom search
(Table 1) were collected on a multiwire area detector (Nicolet/Xentron-
ics, Madison, USA) or on a FAST area detector system (Enraf-Nonius,
Delft, The Netherlands) using a rotating anode X-ray generator. The
data sets were processed using the XDS software suite [62].
Preparation of heavy-atom derivatives and Patterson search 
Attempts to solve the colicin N structure by molecular replacement
methods using the crystal structure of the colicin A pore-forming domain
as a model failed. No solution for the translation function could be found,
even though the rotation function showed significant peaks. For the
heavy-atom derivative searches, crystals were transferred to a synthetic
mother liquor containing 70% ammonium sulphate and 60 mM phos-
phate buffer pH 6.4 or 70% ammonium sulphate and 50 mM acetate
buffer pH 5.6. Various heavy-atom reagents were added in concentra-
tions of 2–30 mM and the crystals were soaked in these solutions for
1–8 days (Table 1). More than 40 different reagents were tested. The
best heavy-atom derivative was obtained by soaking crystals for 2 days in
saturated K2PtI6. This was the first derivative solved using the program
GROPAT [63]. The correct solution was the third best solution in the
ranked program output. Because this derivative had a significant anom-
alous signal, other derivative sites could be located via difference Fourier
calculations using the (at that time apparently single) Pt site. At this
stage, five derivatives turned out to be useful for the initial phasing
(Table 1). The first MIR map was calculated with an initial figure-of-merit
of 0.8 for 3,180 reflections (20–4.5 Å). In the initial map, the α helices of
the pore-forming domain were already visible as thick rods. In the course
of the refinement, more heavy atom sites were successively included. In
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Table 1
Data collection statistics.
Resolution Unique Completeness Rsym* Number
Data (Å) reflections (%) (%) MFID† of sites
Native 3.1 10,644 93.5 8.3 – –
K2PtI6 4.3 3,869 92.9 22.2 24.4 2
K2PtCl4 4.3 3,774 90.6 17.0 21.9 3
UO2(OAc)2 3.4 6,572 84.0 14.0 12.6 1
KOsO4 4.1 4,082 86.3 13.1 12.5 1
KAu(CN)2 3.0 8,237 72.0 22.4 15.8 2
*Rmerge = ΣhklΣi |Ii –〈I〉| / ΣhklΣi |〈I〉|, where Ii is the intensity for the ith
measurement of an equivalent reflection with indices h,k,l. †MFID
(mean fractional isomorphous difference) = Σhkl |FPH–FP| / ΣhklFP, where
FPH refers to derivative data and Fp to native data.
the end, it turned out that 21 of the tested compounds had yielded useful
derivatives, although only 18 were used in the final phase calculation.
(Only the best five derivatives are shown in Table 1 because the others
only made a marginal contribution to the phasing). In total, there were 38
sites of which 19 were different.
Structure refinement
In the first step of the model building, the pore-forming domain of
colicin N was modelled using the structure of the homologous colicin A
domain [41] as a starting structure. This was helpful in speeding up
the refinement process because the electron density maps calculated
from the MIR phases were not readily interpretable. Modelling was
performed using the program O [64]. The phases resulting from this
initial model were combined with the heavy-atom phases and an
improved map was calculated, followed by an adjustment of the
model. This procedure was repeated several times, combining the
model phases with the heavy-atom phases in every step using the
program SIGMAA [65] so that the danger of model bias was mini-
mized. During this procedure, the electron density of the receptor-
binding domain improved considerably, so that density modification
methods (e.g. solvent flattening) were not needed. For the first 24
N-terminal amino acids no density was visible, although the density for
the rest of the molecule was well-defined and unambiguous.
For model refinement, both positional refinement and simulated anneal-
ing refinement were applied using X-PLOR [66]. The final crystallo-
graphic R-factor after refinement with X-PLOR was 19.9% (for 9,099
reflections > 2 sigma, 6.0-3.1 Å). The final refinement was performed
using the program TNT [67] with all the data from 23 Å to 3.1 Å, con-
taining 10,966 unique reflections. The temperature factors were refined
with correlation restraints because of the insufficient resolution of the
data. The crystallographic R-factor after the TNT refinement was 17.3%,
the free R-factor was 31.6% (10% of reflections used for the test set),
and the model exhibited excellent geometry (Table 2). The final model
includes 59 solvent molecules. The final map is of good quality (Figure 7).
All heavy atoms bind to reasonable chemical sites and hence corrobo-
rate the structure. The final structure was analysed using PROCHECK
[68]. The Ramachandran plot shows that all non-glycine residues fall in
either the allowed (92.8%) or additional allowed regions (7.2%). Other
stereochemical parameters such as peptide-bond planarity, α-carbon
tetrahedral distortions and non-bonded interactions are all inside or
better than the allowed ranges according to PROCHECK. In addition to
the PROCHECK tests, the veracity of the model was assessed using
the 3D_1D profile analysis program package [69]. The three-dimen-
sional profile scores were better than 0.3 in all regions of the protein,
corroborating the correctness of the model. The final model was used to
solve the structure of the full-length-derived colicin N crystals by mol-
ecular replacement. After rigid body refinement, the free R-factor was
29.4%. If the data from these crystals were phased only with the pore-
forming domain, then the free R-factor was only 37.0%, but the density
for the secondary structural elements of the receptor-binding domain
could clearly be seen. At no stage was there any evidence for density
corresponding to the translocation domain, which is in full agreement
with circular dichroism results, which show that this domain does not
adopt any regular structure [45,46].
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Table 2
Final refinement statistics.
Parameter Value
Resolution range (Å) 23.0–3.1
Number of reflections used 10,644
Total number of atoms (excluding H) 4,772
Rcrys (23–3.1 Å)* (%) 17.3
Rfree (%) 31.6
Average B-factors (Å2) 34.6
Average B-factor for mainchain atoms (Å2) 29.4
Average B-factor for sidechain atoms (Å2) 39.7
Rmsd for bond lengths (Å) 0.007
Rmsd for angles (°) 1.4
Rmsd for B-factors (Å2) 3.9
*Rcrys = Σhkl ||Fobs| – |Fcalc|| / Σhkl ||Fobs|, where Fobs denotes the observed
structure factor amplitude and Fcalc denotes the structure factor
amplitude calculated from the model. 10% of reflections were used to
calculate Rfree.
Figure 7
The quality of the final colicin N model.
Stereoview showing an omit map of residues
338–352. The residues in this region were
omitted from the model and the map was
calculated after a round of simulated
annealing. The map is contoured at a level of
1.2σ. Part of the α-carbon trace of colicin A
(green) is superimposed [41]. This figure was
produced using BOBSCRIPT [73].
Accession numbers
The atomic coordinates of colicin N have been deposited in the
Brookhaven Protein Data Bank with the accession code 1a87.
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